Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Non-Current Assets (2016 - 2025)

vTv Therapeutics (VTVT) has disclosed Non-Current Assets for 12 consecutive years, with $6000.0 as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 96.08% to $6000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $229000.0 through Dec 2025, down 75.32% year-over-year, with the annual reading at $6000.0 for FY2025, 96.08% down from the prior year.
  • Non-Current Assets hit $6000.0 in Q4 2025 for vTv Therapeutics, down from $38000.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $10.4 million in Q2 2021 to a low of $6000.0 in Q4 2025.
  • Historically, Non-Current Assets has averaged $4.3 million across 5 years, with a median of $5.5 million in 2022.
  • Biggest five-year swings in Non-Current Assets: soared 175.03% in 2021 and later plummeted 96.96% in 2024.
  • Year by year, Non-Current Assets stood at $9.9 million in 2021, then crashed by 37.64% to $6.1 million in 2022, then tumbled by 94.12% to $361000.0 in 2023, then plummeted by 57.62% to $153000.0 in 2024, then plummeted by 96.08% to $6000.0 in 2025.
  • Business Quant data shows Non-Current Assets for VTVT at $6000.0 in Q4 2025, $38000.0 in Q3 2025, and $74000.0 in Q2 2025.